- The exit of GlaxoSmithKline, a leading healthcare and biotech company, one year ago from Nigeria is a big headache for Nigerians
- Almost all drugs heavily affected by GSK’s departure include pain relievers, antibiotics, and others
- The depreciation of the naira has also played a significant role in the rising prices of drugs at pharmacies
Legit.ng journalist Dave Ibemere has over a decade of business journalism experience with in-depth knowledge of the Nigerian economy, stocks, and general market trends.
The cost of essential drugs at pharmacies across the country continues to rise, placing additional strain on Nigerians’ access to healthcare.
